BIRC5 and neoplasm: We found that HM90822B significantly inhibited the expression of XIAP and survivin, reduced cell growth in NSCLC cells, especially cells harboring mutated EGFR, and resulted in tumor regression in xenograft mice originated with these cells, such as HCC827 and PC-9 cells.